Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.75% | 12.10% | -6.39% | -7.95% | -3.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.75% | 12.10% | -6.39% | -7.95% | -3.00% |
| Cost of Revenue | 36.27% | 1.04% | -7.86% | -12.34% | -8.29% |
| Gross Profit | 33.86% | 19.31% | -5.47% | -4.77% | 0.39% |
| SG&A Expenses | 1.37% | -11.85% | -23.96% | -29.15% | -18.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.90% | -9.34% | -21.19% | -25.97% | -15.50% |
| Operating Income | 100.36% | 77.11% | 53.60% | 53.88% | 47.23% |
| Income Before Tax | 74.92% | 59.76% | 43.56% | 45.30% | 52.08% |
| Income Tax Expenses | 5.62% | 30.00% | -2.00% | -7.55% | 2.30% |
| Earnings from Continuing Operations | 73.38% | 58.62% | 43.24% | 45.03% | 51.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -290.32% | -238.10% | -233.33% | 57.14% | 82.35% |
| Net Income | 71.93% | 57.81% | 42.37% | 45.22% | 51.83% |
| EBIT | 100.36% | 77.11% | 53.60% | 53.88% | 47.23% |
| EBITDA | 107.98% | 80.87% | 54.70% | 54.89% | 48.33% |
| EPS Basic | 74.57% | 64.14% | 50.95% | 53.41% | 56.33% |
| Normalized Basic EPS | 75.10% | 64.67% | 50.77% | 53.76% | 36.24% |
| EPS Diluted | 74.57% | 64.14% | 50.95% | 53.41% | 56.33% |
| Normalized Diluted EPS | 75.10% | 64.67% | 50.77% | 53.76% | 36.24% |
| Average Basic Shares Outstanding | 10.33% | 17.62% | 17.56% | 17.56% | 10.31% |
| Average Diluted Shares Outstanding | 10.33% | 17.62% | 17.56% | 17.56% | 10.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |